Clinical Trial Update: Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing extended-release exenatide with placebo in diabetic patients with Type 4 cardiorenal syndrome has completed enrollment with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Chronic Kidney Disease
• Left Ventricular Diastolic Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Exenatide Extended-Release (exenatide extended-release)

Snippet

Sponsor: Baylor Research Institute | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-05-17